452 related articles for article (PubMed ID: 21344354)
1. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
[TBL] [Abstract][Full Text] [Related]
3. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
6. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
7. Subtype classification of hepatocellular adenoma.
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
Bioulac-Sage P; Laumonier H; Rullier A; Cubel G; Laurent C; Zucman-Rossi J; Balabaud C
Liver Int; 2009 Mar; 29(3):459-65. PubMed ID: 18803590
[TBL] [Abstract][Full Text] [Related]
13. Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification.
Kondo F; Fukusato T; Kudo M
Oncology; 2014; 87 Suppl 1():37-49. PubMed ID: 25427732
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins.
Bioulac-Sage P; Laumonier H; Cubel G; Rossi JZ; Balabaud C
Liver Int; 2010 Jan; 30(1):149-54. PubMed ID: 19845852
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
17. Benign hepatocellular nodules: what have we learned using the patho-molecular classification.
Sempoux C; Chang C; Gouw A; Chiche L; Zucman-Rossi J; Balabaud C; Bioulac-Sage P
Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):322-7. PubMed ID: 23876350
[TBL] [Abstract][Full Text] [Related]
18. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract][Full Text] [Related]
19. Adenoma or atypical hepatic focal nodular hyperplasia: role of preoperative imaging and laparoscopic treatment.
Di Carlo I; Pulvirenti E; Toro A; Priolo GD
Surg Laparosc Endosc Percutan Tech; 2010 Jun; 20(3):e105-9. PubMed ID: 20551788
[TBL] [Abstract][Full Text] [Related]
20. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
Ott R; Hohenberger W
Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
